Home > Products > CTLA4 & PD1
> Recombinant Anti-CTLA4 x Anti-PD1 Bispecific Antibody (sdAb-IgG)
Recombinant Anti-CTLA4 x Anti-PD1 Bispecific Antibody (sdAb-IgG) (CAT#: BSSG-397)
Recombinant Anti-CTLA4 x Anti-PD1 Bispecific Antibody (sdAb-IgG) is formed by an IgG and two single domains antibodies (sdAbs). The sdAbs from an anti-PD1 antibody variable domain are respectively connected to the N terminus of the anti-CTLA4 IgG heavy chains or light chains to form sdAb-(H)IgG or sdAb-(L)IgG. It is a type of appended IgGs and has 2+2 antigen-binding valency. This BsAb can bind two factors simultaneously and enhance immune response. It is designed for the research of Tumors therapy.
There are currently no customer reviews or questions for Recombinant Anti-CTLA4 x Anti-PD1 Bispecific Antibody (sdAb-IgG) (BSSG-397). Click the button below to contact us or submit your feedback about this product.